StockVS

The Chemours Company (CC) Análisis de acciones

Materiales Básicos

The Chemours Company

$22.10

+$0.73 (+3.42%)

Última actualización: 26 de mayo de 2026

Historial de Precios

Análisis

Descripción de la empresa

The Chemours Company operates as a global supplier of performance chemicals, serving markets across North America, Asia Pacific, Europe, the Middle East, Africa, and Latin America through three primary segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. This enterprise is classified within the Basic Materials sector and specifically the Specialty Chemicals industry, a classification that signifies its focus on high-value, technical-grade materials essential for various industrial applications. The company currently holds a market capitalization of $3.24 billion and generated total annual revenue of $5.81 billion while employing a workforce of 5,700 individuals. These valuation and revenue figures position The Chemours Company as a mid-cap entity with significant operational scale, indicating that despite fluctuations in the volatile chemical market, the firm maintains a substantial footprint and asset base relative to its peers in the specialty chemicals landscape.

Salud financiera

The company reported a trailing twelve-month revenue of $5.81 billion against a net income of -$386 million, while generating an EBITDA of $637 million; the substantial gap between positive EBITDA and negative net income reveals a cost structure where interest expenses and non-operating costs significantly erode profitability. Operational free cash flow stood at $21.50 million, which suggests that while the company generates liquidity from operations, the absolute amount is modest relative to the total debt load, indicating limited immediate financial flexibility for aggressive expansion without capital raising. The margin profile presents a stark contrast, with a gross margin of 15.7% reflecting production efficiency, an operating margin of 2.0% showing thin operational profitability, and a profit margin of -6.6% confirming that the bottom line is currently suppressed by heavy financial obligations. Liquidity analysis highlights a total cash balance of $670 million compared to total debt of $4.39 billion, resulting in a debt-to-equity ratio of 1,750.60, which characterizes the balance sheet as highly leveraged and sensitive to interest rate environments. Short-term liquidity is supported by a current ratio of 1.78, indicating that the company possesses sufficient current assets to cover its current liabilities, though the high leverage complicates long-term solvency. Return metrics further illustrate capital allocation challenges, with a return on equity of -93.8% and a return on assets of 2.5%, revealing that management effectiveness has been severely impacted by recent losses and the dilutive effect of the substantial debt burden.

Evaluación de valoración

Valuation metrics present a dichotomy between historical performance and forward expectations, evidenced by a trailing P/E ratio that is effectively N/A due to recent losses and a forward P/E of 9.74, implying that the market prices the stock based on anticipated future earnings recovery rather than current profitability. The price-to-book ratio stands at 12.95, indicating that the market values the company at a significant premium over its book value, a discrepancy that investors must reconcile with the current negative net income and high leverage. Alternative valuation measures such as a price-to-sales ratio of 0.56 and an EV/EBITDA of 10.94 suggest that the stock is trading at a discount relative to sales but commands a higher multiple on earnings before interest, taxes, and depreciation, reflecting the market's pricing in of future operational improvements. Price action over the last year has ranged from a low of $9.13 to a high of $21.86, meaning the current price sits in a volatile channel that has seen more than 140% expansion from the trough. The stock exhibits a beta of 1.56, which signifies that the share price is approximately 56% more volatile than the broader market, exposing investors to amplified swings during periods of macroeconomic instability or sector-specific supply chain disruptions.

Growth & Income

Growth dynamics are currently characterized by contraction rather than expansion, with revenue growth year-over-year at -2.1% and earnings growth marked as N/A due to the negative net income, implying that the company is not growing its core business operations at this moment. The company pays a dividend with a yield of 1.6% and a payout ratio of 555.6%, a figure that is mathematically unsustainable as it exceeds the available net income, indicating that the dividend is funded by cash reserves or debt rather than organic earnings generation. Given the negative earnings and excessive payout ratio, the current income profile relies on balance sheet cash rather than profitability, which poses a risk to the continuity of the dividend distribution if cash flows deteriorate further. The overall growth and income profile reflects a company in a transitional phase where capital is required to reduce debt levels and restore profitability before sustainable organic growth and dividend coverage can be re-established.

Comparación con pares

The Chemours Company (CC) opera en la industria de Químicos Especializados. Así se compara con sus pares más cercanos por capitalización de mercado:

Empresa Ticker Cap. de Mercado Ratio P/E
The Chemours Company CC $3.32B N/A
Linde plc LIN $238.09B 34.1
The Sherwin-Williams Company SHW $76.77B 29.9
Ecolab Inc. ECL $71.55B 34.4

El ratio P/E promedio de la industria Químicos Especializados es 54.8x. The Chemours Company cotiza a un P/E de N/A.

Este análisis es generado por IA solo con fines informativos y no constituye asesoramiento financiero. Los datos pueden estar retrasados o ser inexactos. Siempre realice su propia investigación y consulte a un asesor financiero calificado antes de tomar decisiones de inversión.

Acerca de The Chemours Company

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that delivers whiteness, brightness, opacity, durability, efficiency, and protection in applications, including architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard for use in packaging under the Ti-Pure brand name. The Advanced Performance Materials segment products portfolio includes various specialty product solutions, membranes, industrial resins, additives, films, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical markets under the Teflon, Viton, Krytox, and Nafion brand names. It sells its products through direct and indirect channels, as well as through a network of resellers, third-party sales agents, and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

La descripción de la empresa se muestra en inglés.

Visitar sitio web →

Estadísticas Clave

Capitalización
$3.32B
Ratio P/E
N/A
Máximo 52 Sem.
$28.67
Mínimo 52 Sem.
$9.13
Volumen Promedio
3.16M
Beta
1.46
Rendimiento Dividendo
1.58%

Datos proporcionados por Yahoo Finance a través de yfinance. Actualizado diariamente.

Información de la Empresa

Bolsa
NYSE
País
United States
Empleados
5,700